Arcellx (NASDAQ:ACLX – Free Report) had its price objective boosted by Bank of America from $84.00 to $100.00 in a research ...

Truist raised the firm’s price target on Arcellx (ACLX) to $136 from $87 and keeps a Buy rating on the shares after its Q3 results. The ...

Leerink Partners analyst Daina Graybosch has maintained their bullish stance on ACLX stock, giving a Buy rating on November 8. Daina ...

Arcellx (NASDAQ:ACLX – Free Report) had its target price increased by Robert W. Baird from $77.00 to $106.00 in a research ...

Below, we take a look at Arcellx, Inc. (ACLX), which currently has a Momentum Style Score of B. We also discuss some of the main drivers of the Momentum Style Score, like price change and earnings ...

Is Arcellx, Inc. (ACLX) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.

Roughly a year ago, Gilead Sciences revealed that it was laying off about 7% of Kite Pharma’s workforce in a bid to refresh ...

Across the recent three months, 11 analysts have shared their insights on Arcellx (NASDAQ:ACLX), expressing a variety of opinions spanning from bullish to bearish. The table below provides a ...

Investing.com - Arcellx (NASDAQ: ACLX) reported third quarter EPS of $-0.48, $0.14 worse than the analyst estimate of $-0.34. Revenue for the quarter came in at $26.03M versus the consensus ...